Advertisement

Topics

Sobi Inc. Company Profile

06:22 EDT 25th June 2018 | BioPortfolio


News Articles [36 Associated News Articles listed on BioPortfolio]

Invitation - Presentation of Sobi's Q4/FY 2017 Results

The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi's website prior to Read more...

Sobi värvar chef från Pfizer

Fredrik Wetterlundh blir ny HR-chef på Sobi.

EU expands indications for Sobi's Kineret

European regulators expanded treatment indications for Sobi's Kineret, or anakinra, to treat the rare auto-inflammatory disor -More- 

EU regulators expand reach of Sobi’s Kineret

European regulators have expanded the scope of Sobi’s Kineret to include the treatment of Still’s disease, a rare, systemic, multi-organ, auto-inflammatory disorder that affects around 25,...

Ireland procures Sobi therapies for all haemophilia patients

The Republic of Ireland has become the first country in Europe to switch its entire population with haemophilia A and B treated with short-acting replacement clotting factors to Swedish Orphan Biovitr...

Sobi’s metabolic disorder drug secures fast track status in US

The US Food and Drug Administration (FDA) has accepted Swedish Orphan Biovitrum's (Sobi) new drug application and granted fast track status for mucopolysaccharidosis type IIIA (MPS IIIA) drug candidat...

FDA Grants Fast Track Status to Sobi’s Investigational MPS IIIA Drug

Swedish Orphan Biovitrum AB (publ) (Sobi™) announces that the FDA has issued a Study may proceed letter for the first study in humans, thereby accepting the investigational new drug (IND) applicatio...

Sobi receives expanded EU approval for Kineret

Joining its current indication as a treatment for rheumatoid arthritis and cryopyrin-associated periodic syndromes, Sobi’s Kineret has been given approval by the European Commission to include an in...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversi...

Sobi

Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the li...

Sobi Inc.

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

More Information about "Sobi Inc." on BioPortfolio

We have published hundreds of Sobi Inc. news stories on BioPortfolio along with dozens of Sobi Inc. Clinical Trials and PubMed Articles about Sobi Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sobi Inc. Companies in our database. You can also find out about relevant Sobi Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record